The acquisition will accelerate Khiron s growth in Europe by controlling the complete value chain for its products and gaining direct access to German.
The acquisition will accelerate Khiron s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmaciesThe acquisition will provide Khiron.
Pharmadrug Inc.: Pharmadrug Provides Corporate Update and Balance Sheet Status
PharmaDrug or the
Company ) is pleased to provide an update to the status of its balance sheet following the recent general equity market upswing and the increase in PharmaDrug s volume and share price appreciation.
Recent market activity has served to significantly strengthen PharmaDrug s balance sheet and improve its ability to execute on its current business plan. The market has contributed to increased balance sheet strength is four distinct ways. Firstly, PharmaDrug was able to raise in excess of $850,000 by selling marketable securities that the Company valued on its Q3 financials at $200,000, due to a subsequent increase in the value of the shares. Secondly, the Company holds 4.24 million shares of Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC:TRUFF), of which it has not yet sold any shares. The Company also holds 4.24 million warrants of Red Light Holland exercisable at a price of $0.2